Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2000
05/09/2000US6060644 Biosynthesis of plant lipids, and specifically relates to the isolation and use of cloned cuticular lipid genes.
05/09/2000US6060642 Serotonin 5-HT6 receptor knockout mouse
05/09/2000US6060596 Encoded combinatorial chemical libraries
05/09/2000US6060595 Inhibition of viral replication
05/09/2000US6060594 Nucleic acid segments encoding modified bacillus thuringiensis coleopteran-toxic crystal proteins
05/09/2000US6060590 Chitinase related proteins and methods of use
05/09/2000US6060589 Agouti-related proteins
05/09/2000US6060588 Bap-1 proteins
05/09/2000US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
05/09/2000US6060455 Cationic and polycationic amphiphiles, reactives containing the same and their use
05/09/2000US6060451 Thrombin inhibitors based on the amino acid sequence of hirudin
05/09/2000US6060448 Peptide with replacements; foods, beverages
05/09/2000US6060317 Method of transducing mammalian cells, and products related thereto
05/09/2000US6060308 RNA respiratory syncytial virus vaccines
05/09/2000US6060307 Amino acid transporters and uses
05/09/2000US6060303 Use in screening assays and as pharmaceuticals.
05/09/2000US6060300 Thrombin muteins as antidotes for thrombin inhibitors
05/09/2000US6060297 Rho protein
05/09/2000US6060296 Protein kinases
05/09/2000US6060295 Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases
05/09/2000US6060284 Polynucleotide coding for antigenic polypeptides of specific amino acid sequences; for diagnosis and therapy of immune and autoimmune disorders; polymerase chain reaction primers; hybridization probes
05/09/2000US6060283 Nucleotide and amino acid sequences; to treat and/or prevent malignant tumors, viral diseases, bacterial infections and immune diseases without serious side effects; viricides; bactericides; antitumor agents
05/09/2000US6060282 Streptococcus pneumoniae gene sequence Dpj
05/09/2000US6060281 Parasitic helminth PLA2 proteins and nucleic acid molecules
05/09/2000US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
05/09/2000US6060279 Interferon-α-induced protein
05/09/2000US6060278 Expressing recombinant human troponin c and t and a modified recombinant troponin i, then complexing by mixing in neutral ph, aqueous medium in presence of alkaline salt(s); for controls/calibrators in diagnosis of myocardial infarction
05/09/2000US6060276 Nucleotide sequences for proteins involved in signal transduction; for assays to detect/measure ligands; diagnosis and therapy of endocrine disorders; gene therapy; antisense agents; transgenic animals
05/09/2000US6060275 Sprouty protein and coding sequence
05/09/2000US6060274 Extracellular expression of cellulose binding domains (CBD) using Bacillus
05/09/2000US6060273 Multicistronic expression units and their use
05/09/2000US6060272 Human G-protein coupled receptors
05/09/2000US6060271 CDNA fragments corresponding to voltage gated sodium channel genes expressed in peripheral nerve
05/09/2000US6060264 Multiple drug resistance gene atrc of Aspergillus nidulans
05/09/2000US6060262 Regulation of I Kappa B (IκB) degradation and methods and reagents related thereto
05/09/2000US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle
05/09/2000US6060258 With isoelectric point at 6.8 to 7.0 and molecular weight of 50 to 80 kilodaltons, inhibits apoptosis by decreasing cd16 expression, induces expression of cd11b, does not bind to heparin; as prognostic agent
05/09/2000US6060257 Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
05/09/2000US6060255 Having 7s domain in its structure and recovered from collagen solution by pepsin digestion and repeated salt precipitation; for sensitive diagnosis and progression of liver fibrosis
05/09/2000US6060247 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/09/2000US6060244 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs
05/09/2000US6060239 Cellubrevin homologs
05/09/2000US6060238 Method and composition for regulating apoptosis
05/09/2000US6060236 Immunoassay diagnosis in animals or humans by contacting serum sample with virus encoded proteins, and determining the presence of antibody-antigen complexes as indication of infection
05/09/2000US6060065 Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission
05/09/2000US6060064 Chimeric virus-like particle antigen presentation and delivery system
05/09/2000US6060059 Haemophilus adhesion proteins
05/09/2000US6060057 Cloning and sequencing of allergens of Dermatophagoides (house dust mite)
05/09/2000US6060056 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
05/09/2000US6060055 Inducing immunological response in a mammal which comprises delivering a nucleic acid vector to direct expression of div1b polypeptide for expressing said div1b polypeptide in vivo
05/09/2000US6060054 Product for T lymphocyte immunosuppression
05/09/2000US6060052 Expanding primitive stem cells for restoration of hematopoietic capabilities and for providing modified human stem cells for gene therapy applications; transplantation of human hematopoietic stem cells
05/09/2000US6060051 Strain of bacillus for controlling plant diseases and corn rootworm
05/09/2000US6060047 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production
05/09/2000US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety
05/09/2000CA2153584C Cytokine restraining agents
05/09/2000CA2151560C Insulin analog formulations
05/09/2000CA2100586C Htlv-i and htlv-ii peptide antigens and methods
05/09/2000CA2062340C Process for the industrial-scale preparation of a highly pure standardized human von willebrand factor concentrate appropriate for therapeutic use
05/09/2000CA2058940C Targeted liposomes and methods for liposome-protein coupling
05/09/2000CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment
05/09/2000CA2014222C A process for removing toxins from protein solutions
05/09/2000CA2004387C Cyclosporine binding protein and use in an assay for biologically-active cyclosporine
05/09/2000CA1340988C Therapeutic peptides
05/09/2000CA1340985C Peptide derivatives
05/04/2000WO2000025134A1 Assays for ligands for nuclear receptors
05/04/2000WO2000024932A1 Methods of identifying and characterizing mutations within bacterial dna gyrase and fabi
05/04/2000WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000WO2000024914A2 Apomixis conferred by expression of serk interacting proteins
05/04/2000WO2000024913A2 Mn gene and protein
05/04/2000WO2000024906A1 Sequence encoding cysdv coat protein
05/04/2000WO2000024905A1 Plant-optimized genes encoding pesticidal cytc-type toxins
05/04/2000WO2000024904A1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS
05/04/2000WO2000024903A2 Plant-optimized polynucleotides encoding pesticidal 43f- and 80jj1/130-type proteins
05/04/2000WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024900A1 Maize kin17 orthologues and uses thereof
05/04/2000WO2000024899A2 Interleukin-1 homolog zil1a4
05/04/2000WO2000024898A1 Gene for a thrombin inhibitor from the triatoma genus and protein with a thrombin-inhibiting effect
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024895A2 Method and model for hair pigmentation
05/04/2000WO2000024893A2 Methods and compositions for the prevention and treatment of anemia
05/04/2000WO2000024892A1 Genes expressed in human monocytes and human macrophages
05/04/2000WO2000024891A1 Novel g protein-coupled receptor proteins and dnas thereof
05/04/2000WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
05/04/2000WO2000024888A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60)
05/04/2000WO2000024887A2 Method for biotechnological production of ligand binding, especially extracellular, fragments of receptor subunits, especially neuroreceptors and hormone receptors
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024880A1 Transgenic c. elegans as a model organism for research into alzheimer's disease
05/04/2000WO2000024876A2 Spumavirus isolated from humans
05/04/2000WO2000024873A1 Process for recovering heterologous polypeptides from bacterial cells
05/04/2000WO2000024871A2 Kv BETA 1.1-DEFICIENT MICE WITH IMPAIRED LEARNING
05/04/2000WO2000024870A2 Nucleic acids and proteins of the human span-x gene and uses thereof
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024780A2 Compositions and methods for treating polycystic kidney disease
05/04/2000WO2000024779A1 Lysine-rich statherin protein
05/04/2000WO2000024778A1 Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2
05/04/2000WO2000024777A1 Antigenic epitopes with lym-1 reactivity and uses thereof
05/04/2000WO2000024776A1 Novel toll-like receptor and gene thereof
05/04/2000WO2000024774A2 Growth factor related molecules
1 ... 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 ... 2916